| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
ADMA and hyperhomocysteinemia
|
Dayal, Sanjana
|
|
2005
|
10 |
1_suppl |
p. S27-S33
|
article
|
| 2 |
ADMA and oxidative stress may relate to the progression of renal disease: rationale and design of the VIVALDI study
|
Böger, Rainer H
|
|
2005
|
10 |
1_suppl |
p. S97-S102
|
article
|
| 3 |
ADMA: an emerging cardiovascular risk factor
|
Böger, Rainer H
|
|
2005
|
10 |
1_suppl |
p. S1-S2
|
article
|
| 4 |
ADMA: its role in vascular disease
|
Cooke, John P
|
|
2005
|
10 |
1_suppl |
p. S11-S17
|
article
|
| 5 |
ADMA metabolism and clearance
|
Teerlink, Tom
|
|
2005
|
10 |
1_suppl |
p. S73-S81
|
article
|
| 6 |
Arginine metabolism in vascular biology and disease
|
Morris, Sidney M
|
|
2005
|
10 |
1_suppl |
p. S83-S87
|
article
|
| 7 |
Asymmetric dimethylarginine (ADMA) accelerates cell senescence
|
Bode-Böger, Stefanie M
|
|
2005
|
10 |
1_suppl |
p. S65-S71
|
article
|
| 8 |
Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials
|
Böger, Rainer H
|
|
2005
|
10 |
1_suppl |
p. S19-S25
|
article
|
| 9 |
DDAH gene and cardiovascular risk
|
Valkonen, Veli-Pekka
|
|
2005
|
10 |
1_suppl |
p. S45-S48
|
article
|
| 10 |
Endogenous production of nitric oxide synthase inhibitors
|
Anthony, Shelagh
|
|
2005
|
10 |
1_suppl |
p. S3-S9
|
article
|
| 11 |
Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA
|
Sydow, Karsten
|
|
2005
|
10 |
1_suppl |
p. S35-S43
|
article
|
| 12 |
Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA)
|
Maas, Renke
|
|
2005
|
10 |
1_suppl |
p. S49-S57
|
article
|
| 13 |
Quantification of ADMA: analytical approaches
|
Schwedhelm, Edzard
|
|
2005
|
10 |
1_suppl |
p. S89-S95
|
article
|
| 14 |
Spotlight on endothelial progenitor cell inhibitors: short review
|
Thum, Thomas
|
|
2005
|
10 |
1_suppl |
p. S59-S64
|
article
|
Journal description